Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07625748
Recruiting
Transcranial Temporal Interference Stimulation for Children With Autism Spectrum Disorders
Not applicable · China · 1 site
Registry update: 4 Jun 2026
NCT07477587
Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Phase 1 · Australia, China, Georgia, Serbia, United States · 84 sites
Registry update: 24 Sept 2026
NCT07839793
Recruiting
A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients
Phase 4 · Sweden · 5 sites
Registry update: 24 Sept 2026
NCT07597629
Recruiting
A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer
Phase 2 · China · 1 site
Registry update: 16 Jun 2026
NCT07393009
Recruiting
BIO|STREAM.CSP Study
Not applicable · Austria, Australia, Switzerland, Czechia, Germany, Spain, France, Hungary, Israel, Italy, Latvia, New Zealand, Portugal · 46 sites
Registry update: 23 Oct 2026
NCT07652333
Recruiting
The Effects of Strength Training on Muscle Mass and Mental Health in Adults Taking Obesity Medication
Not applicable · United States · 1 site
Registry update: 24 Jun 2026
NCT07570979
Recruiting
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
Phase 1 · Australia, Canada, Germany, Spain, Italy, Japan, South Korea, United States · 12 sites
Registry update: 23 Oct 2026
NCT07598396
Recruiting
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Phase 2 · Argentina, Brazil, Colombia, Italy, Mexico, South Africa · 25 sites
Registry update: 19 Oct 2026
NCT07772791
Recruiting
Online Cohort of Sexual and Gender Minorities: Evaluating Digital Interventions to Improve HIV Pre-Exposure Prophylaxis and Antiretroviral Treatment Uptake and Adherence
Not applicable · Brazil · 1 site
Registry update: 19 Aug 2026
NCT07610447
Recruiting
VR vs Treadmill Exercise in Children With Asthma
Not applicable · 1 site
Registry update: 21 Jul 2026
NCT07591298
Recruiting
Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia
Phase 2 · China · 1 site
Registry update: 31 Jul 2026
NCT07487376
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults
Phase 1 · Australia · 1 site
Registry update: 29 May 2026
NCT07583849
Recruiting
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
Phase 3 · China · 1 site
Registry update: 10 Jun 2026
NCT07632872
Recruiting
Desloratadine as Adjunct Therapy for Rheumatoid Arthritis
Phase 2 · Egypt · 1 site
Registry update: 8 Jun 2026
NCT07577856
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hungary, Israel, India, Italy, Japan, South Korea, Mexico, Malaysia, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Taiwan, United States · 327 sites
Registry update: 3 Nov 2026
NCT06459427
Recruiting
A Multicenter, RAndomIzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With AI-assisted Robotic guidanCe for Hemorrhagic Stroke
Not applicable · China · 15 sites
Registry update: 23 Sept 2026
NCT07650149
Recruiting
Genetic, Microbiological and Behavioral Factors in Obesity
Not applicable · Poland · 2 sites
Registry update: 23 Sept 2026
NCT07722910
Recruiting
Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma
Not applicable · China · 1 site
Registry update: 28 Jul 2026
NCT07527923
Recruiting
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Phase 1 · Belgium, United States · 9 sites
Registry update: 6 Nov 2026
2025-524022-18-00
Recruiting
Discontinuation Outcome in Multiple Myeloma after BCMA-CD3 treatment
Phase 2 · Sweden · 14 sites
Registry update: 16 Feb 2026

Ordered by registry start date. Freshness and sponsorship never change the order.